As of March 2024 Clovis Oncology has a market cap of $11.77 Million. This makes Clovis Oncology the world's 8108th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $11.77 M | 0% |
2023 | $11.77 M | 0% |
2022 | $11.77 M | -96.64% |
2021 | $0.34 B | -29.71% |
2020 | $0.49 B | -13.12% |
2019 | $0.57 B | -39.58% |
2018 | $0.94 B | -72.31% |
2017 | $3.42 B | 99.76% |
2016 | $1.71 B | 27.66% |
2015 | $1.34 B | -29.44% |
2014 | $1.90 B | -6.87% |
2013 | $2.04 B | 387.22% |
2012 | $0.41 B | 37.37% |
2011 | $0.30 B |
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $381.20 B | 3,238,573.31% | ๐บ๐ธ USA |
Pfizer PFE | $157.13 B | 1,334,911.37% | ๐บ๐ธ USA |
AbbVie ABBV | $322.43 B | 2,739,287.24% | ๐บ๐ธ USA |
Eli Lilly LLY | $739.65 B | 6,283,979.59% | ๐บ๐ธ USA |
AstraZeneca AZN | $210.05 B | 1,784,493.03% | ๐ฌ๐ง UK |
BioMarin Pharmaceutical BMRN | $16.47 B | 139,904.03% | ๐บ๐ธ USA |